Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: MedImmune LLC
Condition: Advanced Solid Tumors, Aggressive B-cell Lymphomas
NCT02205333
A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
The study was terminated early at the sponsor's discretion.